This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: The association between Alzheimer's disease (AD) and alleles at the ApoE and the ApoCI loci were tested.
Background: The ApoE alleles, in linkage disequlibrium with ApoCI alleles, have been reported as associated with (ϵ4) or protective for (ϵ2) AD.
Methods: The patients comprise two samples, with a total of 176 whose diagnosis has been confirmed as having probable AD and 226 controls. Genomic DNA was extracted from blood or transformed lymphocytes. Logistic regression was used to determine the effects of alleles at the ApoE and ApoCI loci after allowing for the effects of age and gender.
Results: The effects of the ApoE ϵ2, ϵ3, and ϵ4 alleles were individually studied first; ignoring the ApoCI locus, only the dominant or additive effect of ϵ4 is significant after considering age, gender, and sample-the dominant effect being slightly more significant. The effect ofϵ4 (when only the ApoE locus is included in the model) was larger than recently reported: the odds ratio was 5.57 (95% CI, 3.46 to 8.98). Similarly, when the ApoCI locus was examined, ignoring the ApoE locus, a dominant effect of A was found to be slightly more significant than an additive effect. Finally, models were considered that included the dominant effect ofϵ4, the dominant effect of A, and their interaction. A model that included only the interaction of ApoE and ApoCI yielded the largest odds ratio, 5.89 (95% CI, 3.64 to 9.53).
Conclusions: Association of AD with both the ApoE ϵ4 and ApoCI A alleles was found. The increased risk of AD among carriers of ϵ4 was found to be higher among those who also bear the ApoCI A allele but this may be due to a dose effect of the ϵ4 allele.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Alert Me
Recommended articles
The impact of apolipoprotein E4 on cause of death in Alzheimer's disease
APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome
APOE alleles predict the rate of cognitive decline in Alzheimer disease
Association of APOE Genotype With Heterogeneity of Cognitive Decline Rate in Alzheimer Disease